Fundz

Accellix Raises $10 Million From Broadoak Capital Partners

PRIVATEDec 13, 2021

Amount Raised

$10 Million

Round Type

Funding Round

San JoseBiotechnology

Description

Accellix Inc., which provides quick and accurate flow cytometry results in a compact and easy-to-use platform designed for use by cell therapy companies on the manufacturing floor and at the point-of-need, today announced that it has raised $10 million from BroadOak Capital Partners.

Quick answer

Accellix raised $10 Million in a Funding Round round, dated December 13, 2021. Accellix is based in San Jose, California, United States.

How much did Accellix raise?
Accellix raised $10 Million in a Funding Round round on December 13, 2021.
What does Accellix do?
Accellix aims to enable cell and gene therapy companies to meet their key product QC requirements by providing fast and actionable multi-parameter results using the Accellix instrument and a room temperature stable..
Where is Accellix based and how big is it?
Accellix is based in San Jose, California, United States. Fundz records about 66 employees.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Accellix that raised within 45 days of this round, from Fundz verified event records.

  • NextRNA Therapeutics raised $23M on January 27, 2022.
  • Crossfire Medical Inc raised $3M (Seed) on January 27, 2022.
  • Kula Bio raised $50M (Series A) on January 27, 2022.
  • Septerna raised $100M (Series A) on January 27, 2022.
  • Metagenomi Therapeutics, Inc. raised $175M (Series B) on January 26, 2022.
  • Longeviti Neuro Solutions, LLC raised $4.8M (Seed) on January 26, 2022.

Who to call at Accellix, and when

A new round usually means Accellix is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Accellix raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Accellix, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Accellix. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Accellix

Location

San Jose, California, United States

About

Accellix aims to enable cell and gene therapy companies to meet their key product QC requirements by providing fast and actionable multi-parameter results using the Accellix instrument and a room temperature stable cartridge. Accellix will continue to identify markets where its platform and assay migration expertise can be best combined to create meaningful opportunities.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Accellix raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Accellix's next move

See what Strategic adds

Accellix raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.